| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/03/2007 | US20070099991 Selective rxr ligands |
| 05/03/2007 | US20070099985 Heteroaromate OSC inhibitors |
| 05/03/2007 | US20070099983 Aminocyclohexyl ether compounds and uses thereof |
| 05/03/2007 | US20070099981 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 05/03/2007 | US20070099980 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 05/03/2007 | US20070099975 Imidazole derivatives modulating the sodium channels |
| 05/03/2007 | US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/03/2007 | US20070099904 Pharmaceutical composition for the treatment of cns and other disorders |
| 05/03/2007 | US20070099899 Heterocyclic dihydropyrimidine compounds |
| 05/03/2007 | US20070099892 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
| 05/03/2007 | US20070099868 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
| 05/03/2007 | US20070099850 Combination of acetylsalicylic acid and alpha-glucosidase inhibitors |
| 05/03/2007 | US20070099846 Administering or applying anserine for treating muscle spasm, localized swelling, inflammation, joint pains, muscle fatigue, stress and myocardial infarction optionally with a diuretic |
| 05/03/2007 | US20070099829 Method to prevent accelerated atherosclerosis using (sRAGE) soluble receptor for advanced glycation endproducts |
| 05/03/2007 | US20070099270 Novel neurotrophic factors |
| 05/03/2007 | US20070098808 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases arthritis, skin cancer diabetes, premenstrual syndrome and transdermal transport |
| 05/03/2007 | US20070098787 Composition for preventing and treating varicose veins of lower extremities |
| 05/03/2007 | US20070098777 Pharmaceutical or Food Composition for Treatment or Prevention of Brain Edema |
| 05/03/2007 | US20070098761 Processed fat composition for preventing/ameliorating lifestyle-related diseases |
| 05/03/2007 | US20070098723 Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 05/03/2007 | US20070098701 administering galectins to the brain of the vertebrates to intensify in vivo proliferation of subventricular zone astrocytes and neuron stem cells; treatment of neurodegenerative diseases, brain and nervous system disorders |
| 05/03/2007 | US20070098688 Polymer conjugates of interferon beta-1a and uses |
| 05/03/2007 | DE102005012873B4 Aminocarbonyl substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Aminocarbonyl substituted 8-N-benzimidazoles, process for their preparation and their use as medicaments |
| 05/03/2007 | CA2627303A1 Agent for treatment of circulatory failure |
| 05/03/2007 | CA2627268A1 Process for the preparation of sour cherry seed extract, use of the extract for the preparation of pharmaceutical compositions and pharmaceutical compositions containing said extract |
| 05/03/2007 | CA2627139A1 Novel benzoxathiin derivative |
| 05/03/2007 | CA2626976A1 Heterocyclic aspartyl protease inhibitors |
| 05/03/2007 | CA2622600A1 Rxr agonists and antagonists, alone or in combination with ppar ligands, in the treatment of metabolic and cardiovascular diseases |
| 05/03/2007 | CA2604404A1 An improved process for preparation of irbesartan |
| 05/02/2007 | EP1780278A2 Mammalian calcium channels and related probes, cell lines and methods |
| 05/02/2007 | EP1780212A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE |
| 05/02/2007 | EP1780210A1 Novel cyclic aminobenzoic acid derivative |
| 05/02/2007 | EP1780201A2 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 05/02/2007 | EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands |
| 05/02/2007 | EP1779862A1 Erythropoietin for stimulating endothelial progenitor cells |
| 05/02/2007 | EP1779850A1 Tgf- gene expression inhibitor |
| 05/02/2007 | EP1778693A2 Tricyclic-heteroaryl compounds useful as kinase inhibitors |
| 05/02/2007 | EP1778687A2 Fused ring heterocycle kinase modulators |
| 05/02/2007 | EP1778682A1 Heterocyclic compounds useful as dpp- iv inhibitors |
| 05/02/2007 | EP1778619A2 T type calcium channel inhibitors |
| 05/02/2007 | EP1778267A2 Compositions and methods related to heart failure |
| 05/02/2007 | EP1778245A2 T type calcium channel blockers and the treatment of diseases |
| 05/02/2007 | EP1778235A2 Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors |
| 05/02/2007 | EP1778234A1 Use of pde iii inhibitors for the reduction of heart size in mammals suffering from heart failure |
| 05/02/2007 | EP1778225A2 Pyrrolo(oxo)isoquinolines as 5ht ligands |
| 05/02/2007 | EP1778209A1 Methods and compositions for oral delivery of fts |
| 05/02/2007 | EP1644509B1 Use of fak-related non-kinase in the manufacture of a medicament for the inhibition of stenosis and restenosis |
| 05/02/2007 | EP1635838B1 Phosphodiesterase-5-inhibitors for the prophylaxis and/or treatment of portal hypertension |
| 05/02/2007 | EP1576160B1 Borrelidin-derivatives and their use in medicine |
| 05/02/2007 | EP1552834B1 N-acetyl-l-pipecolic acid as neurotrophic factor production promoter |
| 05/02/2007 | EP1549637B1 1- (indol-3-yl)carbonyl piperazine derivatives |
| 05/02/2007 | EP1539213B1 Cardioprotective therapies based on enzymatic elimination of lipid peroxides by allene oxide synthase |
| 05/02/2007 | EP1488801B1 Chemical igf-i composition for the treatment and prevention of neurodegenerative diseases |
| 05/02/2007 | EP1471871B1 Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin |
| 05/02/2007 | EP1458707B1 New Indol-2-one derivatives |
| 05/02/2007 | EP1441723B1 Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension |
| 05/02/2007 | EP1408952B1 Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
| 05/02/2007 | EP1395606B1 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 05/02/2007 | EP1370256B1 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 05/02/2007 | EP1358184B1 N-(3,3-Dimethylindolin-6-yl){2-[(4-pyridylmethyl)amino}(3-pyridyl)}carboxamide and pharmaceutical compositions thereof. |
| 05/02/2007 | EP1330467B1 Modified, hydroxy-substituted aromatic structures having cytoprotective activity |
| 05/02/2007 | EP1313716B1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists |
| 05/02/2007 | EP1226155B1 18-nor-steroids as selectively active estrogens |
| 05/02/2007 | EP1220830B1 Use of elastase for opening obstructed arteries and veins |
| 05/02/2007 | EP1202734B1 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 05/02/2007 | EP1115693B1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 05/02/2007 | EP0946183B1 Use of pyridazinone or phosphine oxide compounds to treat or prevent cardiac arrhythmia |
| 05/02/2007 | EP0869968B1 Growth-hormone secretagogues |
| 05/02/2007 | CN1956969A 2- ( arylalkoxy ) -1- phenylethylamine derivatives as nk1 antagonist and 5-serotonin reuptake inhibitors |
| 05/02/2007 | CN1956716A Medicine capable of inhibiting activation of transcription factor KLF5 |
| 05/02/2007 | CN1956713A Agent for preventing/amelioration life style-related diseases containing turmeric essential oil component |
| 05/02/2007 | CN1956711A Peroxisome proliferator-activated receptor (PPAR) activator and drugs, supplements, functional foods and food additives using the same |
| 05/02/2007 | CN1955180A 1,2,3,4,7,8-hexahydro-6H-[1,4]diazepino[6,7,1-IJ] quinoline derivatives as antipsychotic and antiobesity agents |
| 05/02/2007 | CN1955178A New benzimidazole derivative |
| 05/02/2007 | CN1955170A Class I tanshinone II A derivative and its application in pharmaceutic |
| 05/02/2007 | CN1954831A Medical composite for treating cardio-cerebral vascular disease and its preparation method and application |
| 05/02/2007 | CN1954830A Medical composite for treating cardio-cerebral vascular disease and its preparation method and application |
| 05/02/2007 | CN1954829A Medical composite for treating cardio-cerebral vascular disease and its preparation method and application |
| 05/02/2007 | CN1954828A Medical composite for treating cardio-cerebral vascular disease and its preparation method and application |
| 05/02/2007 | CN1954825A Supermicro Tongxinluo Chinese herbal composite and its new usage |
| 05/02/2007 | CN1954820A Medical composite for treating curdio-cerebral vascular disease and its preparation method and application |
| 05/02/2007 | CN1954819A Medical composite for treating cardio-cerebral vascular disease and its preparation method and application |
| 05/02/2007 | CN1954804A Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 05/02/2007 | CN1313589C Medicinal liquor and its preparing method |
| 05/02/2007 | CN1313465C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 05/02/2007 | CN1313464C Substituted alkylamine derivatives, preparing method thereof, composition comprising same and use thereof |
| 05/02/2007 | CN1313463C Benzopyran derivatives substituted with secondary amines including imidazole, their preparation and pharmaceutical compositions containing them |
| 05/02/2007 | CN1313450C Tachykinin receptor antagonists |
| 05/02/2007 | CN1313449C New quinazoline hind derivative, medicinal composition containing same and their use |
| 05/02/2007 | CN1313448C Metalloproteinase inhibitors |
| 05/02/2007 | CN1313148C HSA-free formulations of interferon-Beta |
| 05/02/2007 | CN1313146C Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis |
| 05/02/2007 | CN1313136C Hemorrhoid-eliminating suppository and process for preparing the same |
| 05/02/2007 | CN1313133C Medicine composition for treating coronary heart disease and its prepn process |
| 05/02/2007 | CN1313132C Medicine composition for treating coronary heart disease and its prepn process |
| 05/02/2007 | CN1313119C Chinese traditional medicine for treating coronar yheart disease an high blood pressure |
| 05/02/2007 | CN1313114C Chinese traditional medicine decoction for treating heart disease |
| 05/02/2007 | CN1313108C Medicine for treating cardiovascular and cerebrovascular disease |
| 05/02/2007 | CN1313099C Carbon gas gel transfusion agent, its preparing method and its use |
| 05/02/2007 | CN1313090C Aotomatic controlling nurve regulator and its health drinks and foods |